tiprankstipranks
Advertisement
Advertisement

CHJTF Stock Latest News

CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin
Company AnnouncementsCSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin
2d ago
CSPC Pharmaceutical Grants 9.46 Million Restricted Shares Under 2018 Award Scheme
PremiumCompany Announcements
CSPC Pharmaceutical Grants 9.46 Million Restricted Shares Under 2018 Award Scheme
8d ago
CSPC’s Anbenitamab Combo Hits Phase III Goal in HER2-Positive Breast Cancer
PremiumCompany Announcements
CSPC’s Anbenitamab Combo Hits Phase III Goal in HER2-Positive Breast Cancer
11d ago
CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit
PremiumCompany Announcements
CSPC Pharmaceutical Launches 2026 Share Award Scheme as 2018 Plan Nears Limit
16d ago
CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation
PremiumCompany Announcements
CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation
17d ago
CSPC Pharmaceutical Proposes HKD 0.15 Final Dividend for 2025
PremiumCompany AnnouncementsCSPC Pharmaceutical Proposes HKD 0.15 Final Dividend for 2025
17d ago
CSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio
Premium
Company Announcements
CSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio
19d ago
CHJTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHJTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
CSPC Wins China Trial Nod for Monthly GLP-1/GIP Obesity Drug
PremiumCompany Announcements
CSPC Wins China Trial Nod for Monthly GLP-1/GIP Obesity Drug
22d ago
CSPC Innovation Swings to 2025 Loss Despite Revenue Growth, Pressuring CSPC Pharma’s Risk Profile
PremiumCompany Announcements
CSPC Innovation Swings to 2025 Loss Despite Revenue Growth, Pressuring CSPC Pharma’s Risk Profile
25d ago
CSPC Wins China Trial Nod for Novel Inhaled Drug Targeting Interstitial Lung Disease
PremiumCompany Announcements
CSPC Wins China Trial Nod for Novel Inhaled Drug Targeting Interstitial Lung Disease
26d ago
CSPC Pharma Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
CSPC Pharma Sets March Board Meeting to Approve 2025 Results and Consider Dividend
28d ago
CSPC Wins U.S. FDA Nod to Trial Novel Inhaled Drug for Pulmonary Fibrosis
PremiumCompany AnnouncementsCSPC Wins U.S. FDA Nod to Trial Novel Inhaled Drug for Pulmonary Fibrosis
1M ago
CSPC Wins China Trial Nod for Once-Daily Asthma Inhalation Therapy
Premium
Company Announcements
CSPC Wins China Trial Nod for Once-Daily Asthma Inhalation Therapy
1M ago
CSPC Wins China Trial Nod for Hemophilia A Biosimilar Emicizumab
Premium
Company Announcements
CSPC Wins China Trial Nod for Hemophilia A Biosimilar Emicizumab
1M ago
CSPC Pharmaceutical Adds Capital Markets Veteran Zhang Yiwei to Board
PremiumCompany Announcements
CSPC Pharmaceutical Adds Capital Markets Veteran Zhang Yiwei to Board
1M ago
CSPC Pharmaceutical Updates Board Composition and Committee Roles
PremiumCompany Announcements
CSPC Pharmaceutical Updates Board Composition and Committee Roles
1M ago
CSPC Wins U.S. FDA Nod for Trial of Novel Rapid-Dissolving Paclitaxel for Metastatic Breast Cancer
PremiumCompany Announcements
CSPC Wins U.S. FDA Nod for Trial of Novel Rapid-Dissolving Paclitaxel for Metastatic Breast Cancer
1M ago
CSPC Pharmaceutical Unit to Divest 30% Stake in Connected Party Deal
PremiumCompany Announcements
CSPC Pharmaceutical Unit to Divest 30% Stake in Connected Party Deal
1M ago
CSPC Wins China Trial Nod for Ultra-Long-Acting Post-Operative Pain Injection
PremiumCompany AnnouncementsCSPC Wins China Trial Nod for Ultra-Long-Acting Post-Operative Pain Injection
2M ago
CSPC Wins U.S. FDA Nod for Monthly GLP-1/GIP Obesity Injection Trial
Premium
Company Announcements
CSPC Wins U.S. FDA Nod for Monthly GLP-1/GIP Obesity Injection Trial
2M ago
CSPC Wins China Approval for Fast-Acting Intravenous Hypertension Drug
Premium
Company Announcements
CSPC Wins China Approval for Fast-Acting Intravenous Hypertension Drug
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >